Correlation of High Seawater Temperature with Vibrio and Shewanella Infections, Denmark, 2010-2018.

Autor: Gildas Hounmanou YM, Engberg J, Bjerre KD, Holt HM, Olesen B, Voldstedlund M, Dalsgaard A, Ethelberg S

Publikováno v: Emerging infectious diseases [Emerg Infect Dis] 2023 Mar; Vol. 29 (3), pp. 605-608.

Are unexplained adverse health events following HPV vaccination associated with infectious mononucleosis? - A Danish nationwide matched case-control study.

Autor: Krogsgaard LW; Research Unit for Epidemiology, Department of Public Health, Aarhus University, Denmark. Electronic address: l.krogsgaard@ph.au.dk., Helmuth IG; Department of Infectious Diseases Epidemiology, Statens Serum Institut, Copenhagen, Denmark. Electronic address: IDGK@ssi.dk., Bech BH; Research Unit for Epidemiology, Department of Public Health, Aarhus University, Denmark. Electronic address: bhb@ph.au.dk., Plana-Ripoll O; National Centre for Register-based Research, Department of Economics and Business Economics, Aarhus University, Denmark. Electronic address: opr@econ.au.dk., Lützen TH; Research Unit for Epidemiology, Department of Public Health, Aarhus University, Denmark. Electronic address: tina.lutzen@ph.au.dk., Vestergaard HT; Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark., Bjerre KD; Division of Infectious Disease Preparedness, Data Analysis and Integration, Statens Serum Institut, Copenhagen, Denmark. Electronic address: KADB@ssi.dk., Thomsen RW; Department of Clinical Epidemiology, Aarhus University Hospital, Denmark. Electronic address: rwt@clin.au.dk., Mølbak K; Division of Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark; Department of Veterinary and Animal Sciences, University of Copenhagen, Denmark. Electronic address: KRM@SSI.dk., Rytter D; Research Unit for Epidemiology, Department of Public Health, Aarhus University, Denmark. Electronic address: dr@ph.au.dk.

Publikováno v: Vaccine [Vaccine] 2020 Jul 31; Vol. 38 (35), pp. 5678-5684. Date of Electronic Publication: 2020 Jul 02.

Validation of primary and outcome data quality in a Swedish population-based breast cancer quality registry.

Autor: Palmér, Sofia¹ (AUTHOR) sofia.palmer@oru.se, Blomqvist, Carl^1,2 (AUTHOR), Holmqvist, Marit³ (AUTHOR), Lindman, Henrik⁴ (AUTHOR), Lambe, Mats^3,5 (AUTHOR), Ahlgren, Johan^1,3 (AUTHOR)

Publikováno v: BMC Cancer. 3/11/2024, Vol. 24 Issue 1, p1-9. 9p.

Gemcitabine Plus Docetaxel Versus Docetaxel in Patients With Predominantly Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast Cancer: A Randomized, Phase III Study by the Danish Breast Cancer Cooperative Group.

Autor: Nielsen DL, Bjerre KD, Jakobsen EH, Cold S, Stenbygaard L, Sørensen PG, Kamby C, Møller S, Jørgensen CL, Andersson M

Publikováno v: Journal of Clinical Oncology; 12/20/2011, Vol. 29 Issue 36, p4748-4754, 7p

TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group.

Autor: Jørgensen CL; Department of Pathology, Herlev University Hospital, Herlev Ringvej 75, Herlev 2730, Denmark. charlotte.levin.tykjaer.joergensen@regionh.dk., Bjerre C, Ejlertsen B, Bjerre KD, Balslev E, Bartels A, Brünner N, Nielsen DL

Publikováno v: BMC cancer [BMC Cancer] 2014 May 22; Vol. 14, pp. 360. Date of Electronic Publication: 2014 May 22.